<!DOCTYPE html>
<html>
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" type="text/css" href="css/style-manual.css">
    <link rel="stylesheet" href="https://www.w3schools.com/w3css/4/w3.css">
    <script src="js/script.js"></script>
</head>
<body>
    <!--Toma-------------------------------------------------------->
    <div class="bodyDiv" id="idToma">
    <div class="w3-container w3-center w3-animate-left">
        <h2 class="mango">Toma</h2>
    </div>
    <b>Brand Name</b><br>
      Toma Tablet<br><br>

    <b>Generic Name & Strength</b><br>
    Ketotifen Fumarate 1 mg<br><br>

    <b>Dosage Form:</b><br>
    Tablet & Syrup
    <br><br>

    <b>Therapeutic Class:</b><br>
    Cromoglycate & related drugs/<br>
    Sedating Antihistamines(1<sup>st</sup> Generation)
    <br><br>

    <b>Sub Therapeutic class:</b><br>
    <br><br>

    <b>Commercial Pack:</b><br>
    <br><br>

    <b>Price(MRP):</b><br>
    <br><br>

    <b>Flavour:</b><br>
    <br><br>

    <b>Indication:</b><br>    
   Toma is indicated in the following conditions-<br>
      <li> For the prophylactic treatment of bronchial asthma.</li>
      <li> Symptomatic treatment of allergic conditions including rhinitis and conjunctivitis.</li>
        <li> For alleviating the complications of itching, pain and tenderness associated with neurofibroma.</li>
          <li> Symptomatic treatment of allergy such as hayfever, urticaria.</li>
   
    <br><br>

    <b>Dosage & Administration:</b><br>    
    Allergic conditions; Asthma prophylaxis:<br>
    <li> Adults:</li>
    1 mg bid up to 2 mg bid, as needed.
    <li> Children above 3 years:</li>
    1 mg twice daily with food. Alternatively, 0.5-1 mg at night for the 1<sup>st</sup> few days of
    treatment to minimise drowsiness.<br>
    <li> 6 months to 3 years:</li>
    0.25 ml/kg body weight, twice daily (Once in the morning & once in the evening).
    <br><br>

    <b>Administration:</b><br>
    Should be taken withfood
    <br><br>

    <b>Pregnancy & Lactation:</b><br>
    Although there is no evidence of any teratogenic effect, Ketotifen in pregnancy and lactation is not recommended.
    <br><br>

    <b>Children:</b><br>
    <br><br>

    <b>Brand Name Justification:</b><br>
    <br><br>

    <b>Brand Slogan:</b><br>
    <br><br>

    <b>Key Selling Points:</b><br>
    <br><br>

    <b>Target Doctor:</b><br>
    <br>

    <b>Objective:</b><br>
    <br><br>

    <b>Action:</b><br>
    <br><br>

    <b>Mode of Action:</b><br>
    Ketotifen works primarily as a mast cell stabilizer and histamine H1-receptor antagonist, meaning it prevents the release of inflammatory mediators like histamine from mast cells, and also directly blocks histamine from binding to its receptors.
    <br><br>

    <b> Development:</b><br>
    Ketotifen was first developed in Switzerland in 1970 by Sandoz Pharmaceuticals and was initially marketed for the treatment of anaphylaxis.<br>
    <br><br>
        
    <b> Interaction:</b><br>
    Toma may potentiate the effects of sedatives, hypnotics, antihistamines and alcohols. A reversible fall in the platelet count has been observed in a few patients receiving Tifen concomitantly with oral antidiabetic agents and it has been suggested that Toma should therefore be avoided.<br><br>

    <b> Contraindications:</b><br>
    A reversible fall in the platelet count has been observed in a few patients receiving Ketotifen concomitantly with oral antidiabetic agent and it has been suggested that this combination should therefore be avoided. Although there is no evidence of any teratogenic effect, recommendations for Ketotifen in pregnancy or when breast feeding can not be given.
    
    <b> Side Effects:</b><br>
    1-10%<br>
Weight gain (5.3%),<br>
Rash (4%),<br>
Respiratory infection(4%),<br>
Abdominal pain(1.3%),<br>
Increased appetite (1.3%),<br>
Epistaxis (1.3%),<br>
Puffy eyelid (1.3%),<br>
Sleep disturbance (1.3%)<br>
Common Side Effects:<br>
Drowsiness and in isolated cases, dry mouth and slight dizziness may occur at the beginning of treatment but usually disappear spontaneously after a few days.<br><br>
 
    <b> Precautions & Warnings:</b><br>
    It is important to continue the previous treatment for a minimum of two weeks after starting Toma to avoid the possibility of exacerbation of asthma. This applies specially to systemic corticosteroids and ACTH because of the possible existence of adrenocortical insufficiency in steroid dependent patient. If inter current infection occurs, Toma treatment must be supplemented by specific antimicrobial therapy. During the first day of treatment with Toma, reactions may be impaired and patients should be warned not to take charge of vehicle or machinery until the effect of Toma treatment on the individual is known. Patients should be advised to avoid alcoholic drinks. Toma may potentiate the effects of sedatives, hypnotics, antihistamines and alcohol.<br><br>
    
    <b> Overdose Effects:</b><br>
    The reported features of overdosage include confusion, drowsiness, headache, bradycardia, respiratory depression etc. should be watched for. Elimination of the drug with gastric lavage or emessis is recommended. Otherwise, general supportive treatment is all that is required shall be instituted.<br><br>

    <b> Storage Conditions:</b><br>
    Store in a cool and dry place, protect from light. Keep out of the reach of children.<br><br>

    <b> Common Questions about Toma 1 mg Tablet:</b><br>
      <b> What is Toma 1 mg Tablet?:</b><br>
    Toma 1 mg Tablet is an antihistamine medication and a mast cell stabilizer used to treat allergic conditions such as conjunctivitis, asthma, and urticaria (hives).<br><br>
    <b> What is Toma 1 mg Tablet used for?:</b><br>
    Toma 1 mg Tablet is indicated in bronchial asthma, rhinitis, conjunctivitis, hayfever, urticaria.<br><br>
    <b> Are there any pregnancy warnings?:</b><br>
    Asthafen 1mg tablet may be unsafe to use during pregnancy.<br><br>
    <b> Are there any breast-feeding warnings?:</b><br>
    Unknown. Human and animal studies are not available. Please consult your doctor.<br><br>
    <b> Does this affect kidney function?:</b><br>
    There is no data available. Please consult doctor before consuming the drug.<br><br>
    <b> Does this affect liver function?:</b><br>
    There is no data available. Please consult doctor before consuming the drug.<br><br>
  </div>
    <footer>
      <p>Â© 2024 Md. Nurullah. All rights reserved.</p>
  </footer>
  <center><div class="ovalEnd">The End-Toma</div></center><!--End Line---->
  </body>
</html>